Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125977582 | 12597758 | 2 | F | 201604 | 20160802 | 20160726 | 20160809 | EXP | US-BAYER-2016-145286 | BAYER | 51.00 | YR | A | M | Y | 74.84000 | KG | 20160809 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125977582 | 12597758 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 MG, QD | N | UNKNOWN | 0 | 20 | MG | FILM-COATED TABLET | QD | ||||
| 125977582 | 12597758 | 2 | SS | XARELTO | RIVAROXABAN | 1 | N | 0 | FILM-COATED TABLET | ||||||||||
| 125977582 | 12597758 | 3 | SS | XARELTO | RIVAROXABAN | 1 | N | 0 | FILM-COATED TABLET | ||||||||||
| 125977582 | 12597758 | 4 | SS | XARELTO | RIVAROXABAN | 1 | N | 0 | FILM-COATED TABLET | ||||||||||
| 125977582 | 12597758 | 5 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | UNK | N | 0 | |||||||||
| 125977582 | 12597758 | 6 | PS | ACETYLSALICYLIC ACID (} 100 mg) | ASPIRIN | 1 | Unknown | 1500 MG, QD | U | 999999 | 1500 | MG | QD | ||||||
| 125977582 | 12597758 | 7 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | UNK | U | 0 | |||||||||
| 125977582 | 12597758 | 8 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
| 125977582 | 12597758 | 9 | C | LYRICA | PREGABALIN | 1 | Oral | 300 MG, BID | 0 | 300 | MG | BID | |||||||
| 125977582 | 12597758 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | UNK UNK, QD | 0 | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125977582 | 12597758 | 1 | Deep vein thrombosis |
| 125977582 | 12597758 | 2 | Cardiac disorder |
| 125977582 | 12597758 | 3 | Cerebrovascular accident prophylaxis |
| 125977582 | 12597758 | 4 | Embolism venous |
| 125977582 | 12597758 | 5 | Product used for unknown indication |
| 125977582 | 12597758 | 6 | Product used for unknown indication |
| 125977582 | 12597758 | 7 | Product used for unknown indication |
| 125977582 | 12597758 | 8 | Blood cholesterol abnormal |
| 125977582 | 12597758 | 9 | Nerve injury |
| 125977582 | 12597758 | 10 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125977582 | 12597758 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125977582 | 12597758 | Contusion | |
| 125977582 | 12597758 | Eczema | |
| 125977582 | 12597758 | Haemorrhage subcutaneous | |
| 125977582 | 12597758 | Inappropriate schedule of drug administration | |
| 125977582 | 12597758 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125977582 | 12597758 | 1 | 201604 | 0 | ||
| 125977582 | 12597758 | 8 | 2006 | 0 | ||
| 125977582 | 12597758 | 9 | 2006 | 0 | ||
| 125977582 | 12597758 | 10 | 2011 | 0 |